Pages
Products
Human PVRIG Stable Cell Line - HEK293T

Human PVRIG Stable Cell Line - HEK293T

Cat.No. :  CSC-RO0874 Host Cell:  HEK293T

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-RO0874
Description This cell line is engineered to stably overexpress human PVRIG.
Gene PVRIG
Gene Species Homo sapiens (Human)
Host Cell HEK293T
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

1. Studying the interactions between immune cells and cancer cells

2. Studying the mechanisms of resistance to immune checkpoint blockade

3. High-throughput screening

4. Drug target validation

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Applications

Publications

Q & A

Customer Reviews

The PVRIG gene encodes a protein known as Paraoxonase 1 (PON1), which is an enzyme belonging to the paraoxonase family. PON1 is primarily expressed in the liver and plays a crucial role in the detoxification of organophosphate pesticides and other toxic compounds.PON1 is known for its ability to hydrolyze various toxic substrates, including organophosphates, carbonochlorides, and bromates. By breaking down these substrates, PON1 protects the body from their toxic effects and helps maintain cholesterol homeostasis. PVRIG is also involved in the modulation of immune responses. It has been shown to interact with CD96, another member of the Ig superfamily, and to regulate the activation, proliferation, and cytokine production of T cells. This interaction between PVRIG and CD96 contributes to the regulation of immune responses against infections and tumors.PVRIG has been found to be expressed on the surface of various immune cells, including dendritic cells, natural killer cells, and B cells. Its expression and function may be altered in various diseases, including autoimmune diseases and cancer. In summary, the PVRIG gene and its encoded protein, PON1, play a crucial role in the detoxification of toxic compounds and the regulation of immune responses. Dysregulation of PVRIG expression or function may contribute to the development of diseases. Further research into the role and regulation of the PVRIG gene may lead to the development of novel diagnostic and therapeutic strategies for the treatment of these conditions.
The PVRIG gene, or Programmed Cell Death 1 Ligand 2, plays a significant role in the immune response and has become a hotspot in immunotherapy research. PVRIG is expressed on the surface of immune cells and interacts with the PD-1 receptor, which is known to inhibit the activation of T cells. This interaction leads to the suppression of immune responses, which can be detrimental in the fight against tumors. In recent years, researchers have been exploring the potential of targeting the PVRIG gene in cancer immunotherapy. By inhibiting the PVRIG-PD-1 axis, it is possible to restore the function of T cells and enhance the immune response against tumors. Clinical trials have shown promising results, with some patients experiencing significant tumor regression and improved survival rates. Furthermore, PVRIG has also been found to be expressed in various types of cancer cells, making it a promising target for cancer treatment. The application of PVRIG inhibitors in combination with other immunotherapeutic agents is being explored, with the aim of developing more effective and personalized treatment strategies for cancer patients. In conclusion, the PVRIG gene has emerged as a promising target in cancer immunotherapy. Its role in regulating the immune response and its expression in cancer cells make it a valuable target for developing new treatments to enhance the body’s natural ability to fight against tumors.
Customer Q&As
What is the PVRIG gene and its function?

A: The PVRIG gene encodes for the protein V-set domain-containing T cell immunoglobulin and ITIM domain-containing protein (VIR), also known as PVRIG. This protein is a recently discovered inhibitory receptor expressed on the surface of T cells and natural killer (NK) cells. PVRIG plays a role in regulating immune responses by inhibiting the activation and function of these immune cells. It does so by interacting with other proteins on the surface of antigen-presenting cells and T cells.

How does the PVRIG gene contribute to immune response regulation?

A: The PVRIG gene contributes to immune response regulation by inhibiting excessive immune activation and preventing autoimmunity. By interacting with the CD81 and CD82 receptors on T cells and NK cells, PVRIG can inhibit their responses to certain antigens. This inhibition helps maintain immune tolerance and prevents the immune system from attacking healthy cells.

Are there any diseases associated with mutations in the PVRIG gene?

A: Mutations in the PVRIG gene are not commonly associated with specific diseases. However, dysregulation of PVRIG expression or function may lead to alterations in immune responses, potentially affecting the body's ability to mount effective defenses against pathogens or cancer cells.

How is the expression of the PVRIG gene regulated?

A: The expression of the PVRIG gene is regulated by various factors, including cytokines and transcription factors. The activation of T cells and NK cells can lead to the upregulation of PVRIG expression. Additionally, regulatory mechanisms, such as epigenetic modifications and post-translational modifications, can influence the expression of PVRIG, ensuring proper immune responses.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Innovation

The Human PVRIG Stable Cell Line - HEK293T represents a novel and innovative tool for researchers studying immune regulation and cancer immunotherapy. Its development provides new opportunities to investigate the role of PVRIG in immune responses and its potential as a therapeutic target.

Germany

10/16/2020

Continuous updates

The provider of the Human PVRIG Stable Cell Line - HEK293T is committed to continuous updates and improvements, ensuring that the cell line remains relevant and effective as the field evolves. Researchers can benefit from the latest advancements in cell line technology and applications.

French

06/22/2023

Advanced platform

The Human PVRIG Stable Cell Line - HEK293T is developed using a state-of-the-art platform, which incorporates cutting-edge gene editing techniques and cell culture methods. This ensures the production of high-quality and genetically stable cell lines that can be used with confidence in various research applications.

Germany

06/25/2023

Diverse editing strategies

The provider offers a range of editing strategies for the Human PVRIG Stable Cell Line - HEK293T, allowing researchers to choose the most suitable approach for their specific experimental needs. This flexibility enables customization and optimization of the cell line to best suit individual research goals and objectives.

French

09/11/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction